Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

Journal of Enzyme Inhibition and Medicinal Chemistry(2021)10.1080/14756366.2021.1991336Source: DataRank Database

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae is a research paper published in Journal of Enzyme Inhibition and Medicinal Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.33)OA: goldTopics (59)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Ahmed E. M. Elhassanny ORCID,Alessio Nocentini ORCID,Chad S. Hewitt ORCID,Ahmed Elkashif ORCID,Bruce R. Cooper ORCID

Live enrichment

PubMed:34894972 PMC:PMC8667909 OpenAlex:https://openalex.org/W4200156776

Italian Ministry for University and Research

Grant: FISR2019_04819

NIAID NIH HHS

Grant: R01 AI148523

NIAID NIH HHS

Grant: R01 AI153264

National Institutes of Health

Grant: 5R01AI148523-06

Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci

Ministero dell'Istruzione dell'Università e della Ricerca

Grant: unidentified

unidentified

FWCI

3.33

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1991336?needAccess=true

publisherhttps://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1991336?needAccess=true

publisherhttps://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1991336

publisherhttps://www.tandfonline.com/doi/full-xml/10.1080/14756366.2021.1991336

journalhttps://doi.org/10.1080/14756366.2021.1991336

Fields of Study

Enzyme function and inhibitionSynthesis and Catalytic ReactionsPhenothiazines and Benzothiazines Synthesis and Activities0301 basic medicine0303 health sciences03 medical and health sciencesAcetazolamideAnti-Bacterial AgentsCarbonic Anhydrase InhibitorsCarbonic AnhydrasesDose-Response Relationship, DrugEthoxzolamideMicrobial Sensitivity TestsMolecular StructureNeisseria gonorrhoeaeStructure-Activity RelationshipUnited StatesUnited States Food and Drug Administration

MeSH Terms

AcetazolamideAnti-Bacterial AgentsCarbonic AnhydrasesCarbonic Anhydrase InhibitorsDose-Response Relationship, DrugEthoxzolamideMicrobial Sensitivity TestsNeisseria gonorrhoeaeStructure-Activity RelationshipUnited StatesUnited States Food and Drug AdministrationMolecular Structure

Keywords

AcetazolamideNeisseria gonorrhoeaeChemistryCarbonic anhydrasePotencyPharmacologyMicrobiologyEnzymeInternal medicineIn vitroBiochemistryMedicineBiologyAntibioticsCarbonic Anhydrase InhibitorsDrug Repurposingantibiotics; Carbonic anhydrase inhibitors; drug repurposing; Neisseria gonorrhoeae; Acetazolamide; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Ethoxzolamide; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Structure-Activity Relationship; United States; United States Food and Drug AdministrationDose-Response Relationship, DrugMolecular StructureUnited States Food and Drug AdministrationRM1-950Microbial Sensitivity TestsResearch PapersUnited StatesAnti-Bacterial AgentsStructure-Activity RelationshipTherapeutics. PharmacologyEthoxzolamideCarbonic Anhydrases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Clean water and sanitation

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

10.6084/m9.figshare.20424163Taylor & Francis

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

10.6084/m9.figshare.20424163.v1Taylor & Francis

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)